As with many illnesses, the earlier treatment for depression begins, the more effective it is likely to be in alleviating symptoms and reducing the odds of a recurrence. “The sooner you can internalize some of what you learn, the longer you can carry that knowledge with you to help you stay healthy,” says Carol Landau, PhD, a clinical professor of psychiatry and medicine at the Alpert Medical School of Brown University in Providence, Rhode Island.

After having a good medical workup to rule out any underlying causes, a person diagnosed with major depression can be treated a number of ways. The most frequently used approaches are either medication, which is thought to lessen symptoms by acting on neurotransmitters, or chemical messengers in the brain; psychotherapy aimed at altering thought patterns that negatively affect mood; or a combination of the two.

Studies suggest that typically a combination of psychotherapy and medication is more effective than either method alone. The reason isn’t clear. Perhaps medication eases symptoms so that patients are more open to psychotherapy. Or maybe psychotherapy increases the odds that patients will stick to their medication schedule. It could even be that having two clinicians, one who prescribes medication and one who provides talk therapy, enhances the effectiveness of both treatments.

The approach chosen may be dictated by the severity of symptoms. Mild to moderate depression, for instance, is often treated first with psychotherapy. More severe symptoms may require medication from the start.

A meta-analysis published in 2018 in The Lancet offered more insight into why medication alone isn’t necessarily the answer. After investigating the effects of 21 antidepressants in more than 116,400 adults across 522 clinical trials, researchers concluded that “All antidepressants were more effective than placebo,” but with the caveat that the benefits were “mostly modest.”

“Antidepressants can be an effective tool to treat major depression, but this does not necessarily mean that antidepressants should always be the first line of treatment,” says Andrea Cipriani, MD, PhD, lead author of the study and a professor in the department of psychiatry at the University of Oxford in England. “Medication should always be considered alongside other options, such as psychological therapies, where these are available. Patients should be aware of the potential benefits from antidepressants and always speak to the doctors about the most suitable treatment for them individually,” says Dr. Cipriani.

Which Types of Psychotherapy Work Best?

Psychotherapy always includes talking with a trained professional focused on helping you make positive changes in your thoughts and behaviors to ease your symptoms. But there’s some evidence that certain types may be more effective for depression than others.

 Those include:

  • Cognitive Behavioral Therapy Often referred to simply as CBT, this is a systematic approach aimed at identifying and altering negative thought patterns.
  • Interpersonal Therapy This approach focuses on increasing happiness by improving how you interact with others.
  • Psychodynamic Therapy This approach aims to reduce the negative influence of past life events and traumas by providing insight into how those events affect your current behavior.

Options for Treatment-Resistant Depression

When traditional treatments don’t work, psychiatrists may turn to brain stimulation therapy, the best-known options of which are:

  • Electroconvulsive Therapy Also known as shock treatment, this option involves using short electrical impulses to cause seizures that are thought to repair faulty wiring in the brain. It is done under anesthesia.
  • Repetitive Transcranial Magnetic Stimulation Done while the patient is awake and alert, this treatment uses a magnet instead of an electrical current to stimulate brain regions linked to mood.

New Treatments for Major Depression

Recent research has shown that ketamine, primarily used as a tranquilizer in veterinary medicine and often abused as a recreational club drug called Special K, can rapidly lift people out of depression and keep even chronically suicidal patients feeling well for days or even weeks.

Scientists testing ketamine at the University of Illinois at Chicago College of Medicine reported in a study published in 2018 in Molecular Psychiatry that 66 percent of patients felt better within hours after receiving a single infusion of ketamine through an IV (intravenously).

In 2019, the U.S. Food and Drug Administration approved esketamine (Spravato), a nasal spray derived from ketamine, for people who haven’t responded to other depression treatments. Esketamine can only be administered at certified treatment centers, due to the potential for abuse and addiction.

Hallucinogenic mushrooms, LSD, and other psychedelics are emerging as another potential new treatment option for depression.

Anecdotal accounts and federally approved studies, as reported in Michael Pollan’s best-selling book on the subject, How to Change Your Mind, suggest that miniscule doses — one-twentieth to one-tenth of a recreational dose — significantly lessen depression, possibly by increasing new connections in the brain.

In 2019, John Hopkins Medicine in Bethesda, Maryland, launched the Center for Psychedelic and Consciousness Research, a first-of-its-kind initiative studying compounds like psilocybin (the active ingredient in hallucinogenic mushrooms) and their effect on a range of mental health problems, including treatment-resistant depression.

Leave a Reply

Your email address will not be published. Required fields are marked *